The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2019

Filed:

Oct. 13, 2016
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Mariusz A. Wasik, Ardmore, PA (US);

Qian Zhang, Philadelphia, PA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7068 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); A61K 31/706 (2006.01); A61K 31/5355 (2006.01); A61K 38/17 (2006.01); C12N 15/113 (2010.01); C12Q 1/48 (2006.01); G01N 33/574 (2006.01); A61K 39/395 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01);
U.S. Cl.
CPC ...
A61K 31/706 (2013.01); A61K 31/5355 (2013.01); A61K 38/1709 (2013.01); A61K 39/3955 (2013.01); C07K 16/18 (2013.01); C07K 16/3061 (2013.01); C12N 15/1135 (2013.01); C12Q 1/485 (2013.01); G01N 33/57484 (2013.01); C07K 2317/76 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); G01N 2333/91011 (2013.01); G01N 2800/52 (2013.01);
Abstract

The invention provides methods of inhibiting epigenetic gene silencing in a cell expressing NPM/ALK or decreasing NPM/ALK content in a cell, by contacting a cell with an agent capable of increasing the concentration of Stat5a protein or its functional analog. Further, the invention provides a method of treating malignancies expressing oncogenic kinase by administering to a patient affected with a malignancy an agent capable of increasing the concentration of Stat5a protein or its epigenetically silenced functional tumor suppressor analog in a malignant cell. Finally, it provides a method to diagnose malignancy and monitor patient's response to therapy by analysis of the degree of DNA methylation of the gene encoding for Stat5a or its analog, their mRNA, or protein.


Find Patent Forward Citations

Loading…